Syndax Pharmaceuticals Stock Analysis

Syndax Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Syndax Pharmaceuticals was at this time reported as 2.5. The company has Price/Earnings (P/E) ratio of 126.11. Syndax Pharmaceuticals recorded a loss per share of 3.85. The entity had not issued any dividends in recent years. Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts. Syndax Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. To find out more about Syndax Pharmaceuticals contact Michael MBA at 781 419 1400 or learn more at https://syndax.com.

Syndax Pharmaceuticals Investment Alerts

Syndax Pharmaceuticals Upcoming and Recent Events

Syndax Largest EPS Surprises

View All Earnings Estimates

Syndax Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Syndax Stock Institutional Investors

Note, although Syndax Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Syndax Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 887.15 M.

Syndax Profitablity

Management Efficiency

Syndax Pharmaceuticals has return on total asset (ROA) of (0.3629) % which means that it has lost $0.3629 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.937) %, meaning that it created substantial loss on money invested by shareholders. Syndax Pharmaceuticals' management efficiency ratios could be used to measure how well Syndax Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.46 in 2025. Return On Capital Employed is likely to drop to -0.57 in 2025. At this time, Syndax Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 127.8 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 206.2 K in 2025.

Technical Drivers

As of the 24th of July, Syndax Pharmaceuticals has the Risk Adjusted Performance of 0.0121, coefficient of variation of 22680.17, and Semi Deviation of 5.78. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Syndax Pharmaceuticals, as well as the relationship between them.

Syndax Pharmaceuticals Price Movement Analysis

Syndax Pharmaceuticals Insider Trading Activities

Syndax Pharmaceuticals Outstanding Bonds

Syndax Pharmaceuticals Predictive Daily Indicators

Syndax Pharmaceuticals Corporate Filings

Syndax Pharmaceuticals Forecast Models

Syndax Pharmaceuticals' time-series forecasting models are one of many Syndax Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Syndax Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Syndax Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Syndax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Syndax Pharmaceuticals. By using and applying Syndax Stock analysis, traders can create a robust methodology for identifying Syndax entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Syndax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Syndax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Syndax Pharmaceuticals stock analysis indicators help investors evaluate how Syndax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Syndax Pharmaceuticals shares will generate the highest return on investment. By understating and applying Syndax Pharmaceuticals stock analysis, traders can identify Syndax Pharmaceuticals position entry and exit signals to maximize returns.

When running Syndax Pharmaceuticals' price analysis, check to measure Syndax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syndax Pharmaceuticals is operating at the current time. Most of Syndax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syndax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syndax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syndax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.